KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $72,000 | -99.8% | 400 | -99.9% | 0.00% | -99.9% |
| Q2 2017 | $47,533,000 | +31.5% | 458,500 | -0.5% | 0.87% | +223.0% |
| Q1 2017 | $36,160,000 | +73.9% | 460,700 | -0.6% | 0.27% | +65.6% |
| Q4 2016 | $20,792,000 | -21.0% | 463,700 | -1.6% | 0.16% | -18.1% |
| Q3 2016 | $26,327,000 | +17.0% | 471,300 | +4.7% | 0.20% | +15.0% |
| Q2 2016 | $22,510,000 | +8.5% | 450,200 | -0.3% | 0.17% | +8.1% |
| Q1 2016 | $20,738,000 | -26.5% | 451,700 | -1.3% | 0.16% | -26.9% |
| Q4 2015 | $28,197,000 | +7.6% | 457,600 | -2.8% | 0.22% | +3.3% |
| Q3 2015 | $26,203,000 | -12.3% | 470,600 | -4.0% | 0.21% | -1.9% |
| Q2 2015 | $29,887,000 | +4.4% | 490,200 | -1.2% | 0.22% | +1.9% |
| Q1 2015 | $28,627,000 | +1.1% | 496,300 | +1.1% | 0.21% | +8.2% |
| Q4 2014 | $28,304,000 | – | 490,800 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 2,358,084 | $105,736,000 | 48.63% |
| BAINCO INTERNATIONAL INVESTORS | 1,151,540 | $51,635,000 | 8.76% |
| Coastal Bridge Advisors, LLC | 250,040 | $11,212,000 | 4.36% |
| NEXTHERA CAPITAL LP | 150,000 | $6,726,000 | 3.94% |
| Casdin Capital, LLC | 94,000 | $4,215,000 | 3.48% |
| MENORA MIVTACHIM HOLDINGS LTD. | 1,258,899 | $56,449,000 | 2.90% |
| DIALECTIC CAPITAL MANAGEMENT, LP | 85,000 | $3,812,000 | 2.14% |
| SECTORAL ASSET MANAGEMENT INC | 372,223 | $16,690,000 | 1.85% |
| ARK Investment Management | 97,313 | $4,364,000 | 1.59% |
| BB BIOTECH AG | 800,000 | $35,872,000 | 1.33% |